Oncolytic Newcastle disease virus expressing a checkpoint inhibitor as a radioenhancing agent for murine melanoma

by Gayathri Vijayakumar, Peter Palese, Peter H. Goff
Published 2019-11-01

Intersection of Two Checkpoints: Could Inhibiting the DNA Damage Response Checkpoint Rescue Immune Checkpoint-Refractory Cancer?

by Peter H. Goff, Rashmi Bhakuni, Thomas Pulliam, Jung Hyun Lee, Evan T. Hall, Paul Nghiem
Published 2021-07-01

Adjuvants and immunization strategies to induce influenza virus hemagglutinin stalk antibodies.

by Peter H Goff, Dirk Eggink, Christopher W Seibert, Rong Hai, Luis Martínez-Gil, Florian Krammer, Peter Palese
Published 2013-01-01

In Regard to Barker

by Peter H. Goff, MD, PhD, Stephanie K. Schaub, MD, Maclean M. Cook, BS, Paul N. Nghiem, MD, PhD, Upendra Parvathaneni, MBBS, FRANZCR
Published 2021-05-01

2D kV orthogonal imaging with fiducial markers is more precise for daily image guided alignments than soft-tissue cone beam computed tomography for prostate radiation therapy

by Peter H. Goff, MD, PhD, Louis B. Harrison, MD, FASTRO, Eli Furhang, PhD, Evan Ng, MBBS, FRANZCR, Stephen Bhatia, RTT, Frieda Trichter, DSc, Ronald D. Ennis, MD
Published 2017-07-01